UroGen Pharma Ltd. (URGN)
24.92
+2.38
(+10.56%)
USD |
NASDAQ |
Apr 20, 16:00
25.00
+0.08
(+0.32%)
After-Hours: 20:00
UroGen Pharma EPS Diluted (Quarterly) : -0.5453 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Cogent Biosciences, Inc. | -0.6934 |
| Puma Biotechnology, Inc. | 0.2608 |
| Zymeworks, Inc. | -0.547 |
| Xeris Biopharma Holdings, Inc. | 0.0615 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.36M |
| Revenue (Quarterly) | 37.84M |
| Total Expenses (Quarterly) | 64.20M |
| Enterprise Value | 1.221B |
| Gross Profit Margin (Quarterly) | 91.31% |
| Profit Margin (Quarterly) | -69.68% |
| Earnings Yield | -12.88% |
| Normalized Earnings Yield | -12.88 |